News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Genetix Group plc H1 Pretax Rises 5 Pct To 1.2 Mln Stg; Sales Up 4 Pct At 6.0 Mln
August 8, 2006
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Genetix Group PLC, the health technology group, said its first-half pretax profit rose 5 pct to 1.2 mln stg, from 1.1 mln a year ago, on sales that were up 4 pct at 6.0 mln stg, from 5.8 mln.
Twitter
LinkedIn
Facebook
Email
Print
Earnings
Europe
MORE ON THIS TOPIC
IPO
Apnimed eyes up to $160M IPO to prep for sleep apnea drug launch
July 28, 2026
·
2 min read
·
Tristan Manalac
Rare diseases
Oak Hill takes SPAC track to Nasdaq with Roche asset in tow
July 28, 2026
·
2 min read
·
Tristan Manalac
FDA
UPDATE: FDA disputes Capricor’s claims of Phase 3 success for DMD cell therapy
July 27, 2026
·
3 min read
·
Heather McKenzie
Business
Gossamer regains rights to lung disease asset from Chiesi after Phase 3 fail
July 27, 2026
·
3 min read
·
Gabrielle Masson